EGF-r detection kit and method
AssigneeDako Corporation
InventorsElizabeth O. Spaulding, Marc E. Key
Life of this patent
Estimating the term…
Loading patent…
AssigneeDako Corporation
InventorsElizabeth O. Spaulding, Marc E. Key
Estimating the term…
A kit containing the reagents necessary for the qualitative or quantitative demonstration of epidermal growth factor receptor (EGFR) in formalin-fixed, paraffin-embedded tissue sections. A immunohistochemical staining procedure is employed which utilizes a primary monoclonal mouse antibody that selectively binds to EGFR. The primary antibodies bound to tissue antigens are detected using a peroxidase labeled polymer that is conjugated with secondary anti-mouse immunoglobulin antibodies. The enzymatic conversion of the subsequently applied chromogen results in formation of a visible reaction product at the site of the EGFR antigen. Following development of the chromogen, specimens may then be counterstained and coverslipped. Results are interpreted using a light microscope or other optical imaging device. The detection system is adapted for both manual and automated staining.
A kit operable for detecting the presence of epidermal growth factor receptor in cells comprising a tissue, the kit comprising:
A kit operable for detecting the presence of epidermal growth factor receptor in cells comprising a tissue, the kit comprising:
A method for identifying a patient having a tumor wherein treatment of the tumor by anti-EGFR antibody therapy is indicated comprising detecting EGFR in formalin-fixed, paraffin-embedded tissue sections derived from the patient's tumor.
A method for detecting the presence of epidermal growth factor in cells comprising a tissue specimen wherein the tissue specimen has been fixed by immersion in formalin and mounted on a slide comprising the steps of:
Dependencies are inferred from the claim text.